Clinical trials
Phase 1/2 Triple Negative Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Unknown status | 5 |
| Completed | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Biotech | 3 |
| Genmab | 2 |
| Abbisko Therapeutics Co, Ltd | 1 |
| AstraZeneca | 1 |
| BeiGene | 1 |
| CytosinLab Therapeutics Co., Ltd. | 1 |
| Essen Biotech | 1 |
| Fudan University | 1 |
| Huihua Xiong | 1 |
| Innolake Biopharm | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Breast Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Endometrial Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Pancreatic Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.